Business Wire

MedTest Dx Manufactures the Only FDA Approved Quantitative Test for G6PD, Critical when Considering COVID-19 Treatment with Chloroquine and Hydroxychloroquine

-Accurate, Plug and Play Test Measures G6PD Activity in Whole Blood, Detecting Both Presence and Severity of G6PD Deficiency, Providing Key Insight to Inform Drug Therapy Options CANTON, ...
Nature

Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States?

Glucose-6-phosphate dehydrogenase (G6PD) deficiency, a common X-linked enzymopathy can lead to severe hyperbilirubinemia, acute bilirubin encephalopathy and kernicterus in the United States. Neonatal ...